Woburn, MA, United States of America

Maniyan Padmanilayam


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2004-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Maniyan Padmanilayam in Antimalarial Research

Introduction

Maniyan Padmanilayam is a notable inventor based in Woburn, MA (US). He has made significant contributions to the field of antimalarial research, holding a total of 2 patents. His work focuses on developing effective treatments for malaria, schistosomiasis, and cancer.

Latest Patents

His latest patents include the development of spiro and dispiro 1,2,4-trioxolane antimalarials. These patents describe a means and method for treating malaria, schistosomiasis, and cancer using a spiro or dispiro 1,2,4-trioxolane. The preferred compounds include a spiroadamantane group on one side of the trioxolane group and a spirocyclohexyl on the other side. The spirocyclohexyl ring is preferably substituted at the 4-position. Compared to artemisinin semisynthetic derivatives, the compounds of this invention are structurally simple, easy to synthesize, non-toxic, and potent against malarial parasites.

Career Highlights

Maniyan Padmanilayam is associated with Medicines for Malaria Venture (MMV), where he continues to advance his research in antimalarial treatments. His innovative approaches have the potential to significantly impact public health by providing new solutions to combat malaria and related diseases.

Collaborations

He has collaborated with notable researchers such as Jonathan L Vennerstrom and Yuxiang Dong, enhancing the scope and effectiveness of his research efforts.

Conclusion

Maniyan Padmanilayam's contributions to antimalarial research through his patents and collaborations highlight his commitment to finding effective treatments for serious diseases. His work is paving the way for advancements in medical science and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…